Table 1.
Intervention Phase | ||||
---|---|---|---|---|
Control (n=626) | Checklist (n=470) | Electronic (n=624) | p-value | |
Age - Mean (SD) | 55.8 (11.2) | 56.1 (11.3) | 58.3 (11.3) | 0.009 |
Female Sex - % | 36.3% | 42.8% | 36.9% | 0.61 |
Non-White Ethnicity - % | 20.1% | 31.9% | 29.7% | 0.029 |
Charlson Comorbidity Index - Mean (SD) | 4.23 (2.63) | 4.0 (2.6) | 4.4 (2.7) | 0.093 |
Model for End-Stage Liver Disease Score - Mean (SD) | 17.7 (7.08) | 17.7 (7.1) | 17.4 (7.5) | 0.46 |
Admission Sodium Level (meq/L)- Mean (SD) | 134.4 (5.65) | 134.5 (5.8) | 134.3 (5.9) | 0.89 |
Admission in Past 30 days - % | 22.7% | 22.1% | 16.7% | 0.041 |
Payor= Medicare or Private Insurance - % | 70.6% | 73.0% | 72.9% | 0.82 |
Primary Etiology of Liver Disease (%) (%, does not sum to 100) | ||||
Alcoholic Liver Disease | 34.0% | 30.0% | 29.3% | 0.39 |
Hepatitis C | 44.9% | 40.4% | 40.2% | 0.50 |
Hepatitis B | 5.4% | 4.47 | 4.3% | 0.64 |
Biliary Cirrhosis | 1.8% | 4.5% | 2.4% | 0.63 |
Active Problems during hospitalization (%, does not sum to 100) | ||||
Gastrointestinal Bleeding | 28.3% | 29.8% | 31.9% | 0.59 |
Ascites | 43.6% | 43.8% | 43.6% | 1.0 |
Hepatic Encephalopathy | 47.8% | 43.8% | 47.4% | 0.72 |
Spontaneous Bacterial Peritonitis | 6.9% | 6.6% | 9.1% | 0.25 |
Alcoholic Hepatitis | 7.8% | 9.2% | 5.6% | 0.11 |
Hepatocellular Carcinoma | 3.4% | 2.5% | 5.3% | 0.32 |
Previous Transplant | 19.3% | 22.8% | 21.3% | 0.63 |
SD = standard deviation